Bruce D Levy Selected Research

5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acid

1/2017	Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes.
1/2012	Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways.
9/2011	Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses.
6/2011	NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation.
1/2010	The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury.
8/2008	Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce D Levy Research Topics

Disease

54	Inflammation (Inflammations) 01/2022 - 09/2002
45	Asthma (Bronchial Asthma) 11/2022 - 09/2002
16	Pneumonia (Pneumonitis) 01/2022 - 09/2002
8	Sepsis (Septicemia) 09/2021 - 02/2016
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020 - 11/2014
7	Acute Lung Injury 01/2019 - 04/2005
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2012
6	Infections 01/2021 - 02/2007
6	Respiratory Hypersensitivity 01/2018 - 09/2002
5	COVID-19 09/2021 - 09/2020
4	Lung Injury 01/2021 - 08/2015
4	Lung Diseases (Lung Disease) 08/2020 - 12/2005
3	Peritonitis 01/2022 - 10/2005
3	Neoplasms (Cancer) 01/2022 - 01/2014
3	Obesity 01/2021 - 01/2017
2	Metaplasia 01/2021 - 08/2012
2	Hypertension (High Blood Pressure) 01/2021 - 01/2016
2	Respiratory Insufficiency (Respiratory Failure) 10/2020 - 01/2014
2	Critical Illness (Critically Ill) 08/2020 - 01/2017
2	Bacterial Pneumonia 01/2018 - 01/2010
2	Eosinophilia 01/2018 - 08/2012
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Emphysema 01/2022
1	Cough 10/2021

Drug/Important Bio-Agent (IBA)

20	LipidsIBA 09/2021 - 05/2003
20	lipoxin A4IBA 10/2020 - 10/2005
15	LipoxinsIBA 01/2016 - 09/2002
13	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 10/2005
12	LeukotrienesIBA 01/2021 - 09/2002
10	CytokinesIBA 01/2021 - 08/2007
10	EicosanoidsIBA 01/2018 - 09/2002
8	ProstaglandinsIBA 01/2017 - 09/2002
7	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2016
7	Interleukin-6 (Interleukin 6)IBA 10/2020 - 04/2006
6	AllergensIBA 01/2021 - 01/2003
6	Interleukin-13IBA 01/2021 - 09/2002
6	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018 - 01/2012
6	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 01/2017 - 08/2008
5	OvalbuminIBA 01/2022 - 07/2015
5	LigandsIBA 09/2021 - 01/2017
5	protectin D1IBA 01/2021 - 01/2007
5	Immunoglobulin E (IgE)IBA 01/2021 - 12/2010
5	AcidsIBA 01/2019 - 04/2006
5	Interleukin-5 (Interleukin 5)IBA 01/2016 - 09/2002
4	Bronchodilator Agents (Bronchodilators)IBA 11/2022 - 02/2007
4	resolvin D1IBA 01/2021 - 01/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 05/2003
4	Arachidonic Acid (Vitamin F)IBA 10/2014 - 10/2005
3	Biological ProductsIBA 01/2022 - 02/2015
3	SphingolipidsIBA 01/2022 - 09/2013
3	Triamcinolone (Aristocort)FDA Link 01/2021 - 01/2019
3	resolvin D2IBA 01/2021 - 01/2017
3	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 10/2020 - 11/2014
3	Methacholine Chloride (Methacholine)FDA Link 01/2020 - 01/2007
3	Interleukin-17 (Interleukin 17)IBA 01/2018 - 07/2013
3	Dinoprostone (PGE2)FDA Link 01/2018 - 03/2015
3	NeuropeptidesIBA 11/2017 - 07/2015
3	Leukotriene B4IBA 01/2017 - 06/2010
3	Essential Fatty AcidsIBA 08/2016 - 01/2016
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2008 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	SmokeIBA 01/2022 - 03/2015
2	Endothelin-1 (Endothelin 1)IBA 01/2022 - 09/2021
2	signal peptide receptorIBA 01/2022 - 09/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 09/2011
2	Sodium Channel BlockersIBA 10/2021 - 07/2015
2	AerosolsIBA 10/2021 - 09/2011
2	QX-314IBA 10/2021 - 07/2015
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 02/2007
2	Interleukin-10 (Interleukin 10)IBA 09/2020 - 07/2003
2	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2019 - 01/2012
2	Phosphates (Orthophosphate)IBA 10/2019 - 02/2007
2	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2019 - 06/2011
2	Prostaglandins EIBA 01/2018 - 04/2006
2	Neutralizing AntibodiesIBA 01/2018 - 07/2013
2	Phospholipase DIBA 01/2018 - 10/2005
2	OzoneIBA 01/2018 - 01/2017
2	Epoxide HydrolasesIBA 01/2017 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2008
2	EnzymesIBA 01/2016 - 09/2008
2	Docosahexaenoic AcidsIBA 01/2016 - 01/2007
2	Chemotactic FactorsIBA 03/2015 - 12/2013
2	Peptides (Polypeptides)IBA 12/2013 - 08/2012
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2011 - 04/2010
2	Prostaglandins DIBA 08/2007 - 01/2007
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2022
1	ovalbumin-alumIBA 01/2022
1	CalciumIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022
1	Fish OilsIBA 01/2022
1	Enterotoxins (Enterotoxin)IBA 01/2022
1	CationsIBA 10/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2021

Therapy/Procedure

15	Therapeutics 01/2021 - 04/2005
2	Critical Care (Surgical Intensive Care) 08/2020 - 02/2007
2	Ligation 11/2016 - 02/2016
2	Punctures 11/2016 - 02/2016
1	Injections 01/2022